Cancer drug points way to new Alzheimer’s approach
An altered version of the cancer drug Gleevec could form the basis of a new class of drugs that block the development of brain-damaging plaques in Alzheimer’s disease, U.S. researchers said on Wednesday.
Read more on Reuters via Yahoo! News

Breakthrough test gives fast diagnosis of drug-resistant TB
A groundbreaking new test can accurately diagnose drug-resistant tuberculosis (TB) in as little as two hours, researchers wrote in a study published Thursday in the New England Journal of Medicine.
Read more on AFP via Yahoo! News

AstraZeneca’s Seroquel XR Approved In EU As Add-on Treatment Of Major Depressive Disorder – Update
British drug maker AstraZeneca plc ( AZN, AZN.L) Thursday announced that the European Commission approved once-daily Seroquel Extended Release tablets as an add-on treatment of major depressive episodes in patients with Major Depressive Disorder or MDD, who have not responded well to antidepressant monotherapy.
Read more on RTT News